title: [STAT5, a new therapeutic target against the relapse of chronic myelogenous leukemia?].
authors.forename: Luana
authors.initials: L
authors.lastname: Casetti
authors.forename: Séverine
authors.initials: S
authors.lastname: Martin-Lannerée
authors.forename: Imen
authors.initials: I
authors.lastname: Najjar
authors.forename: Isabelle
authors.initials: I
authors.lastname: Dusanter-Fourt
mesh_terms: D000970:Antineoplastic Agents; D001549:Benzamides / Q000627:therapeutic use; D002470:Cell Survival; D019008:Drug Resistance, Neoplasm; D016044:Fusion Proteins, bcr-abl / Q000037:antagonists & inhibitors / Q000502:physiology; D016313:Genes, abl / Q000235:genetics; D006412:Hematopoietic Stem Cells / Q000502:physiology; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy* / Q000235:genetics; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control; D010879:Piperazines / Q000627:therapeutic use; D047428:Protein Kinase Inhibitors; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors; D011743:Pyrimidines / Q000627:therapeutic use; D050799:STAT5 Transcription Factor / Q000502:physiology*
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D047428:Protein Kinase Inhibitors; D011743:Pyrimidines; D050799:STAT5 Transcription Factor; D000068877:Imatinib Mesylate; D011505:Protein-Tyrosine Kinases; D016044:Fusion Proteins, bcr-abl